A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
United States, CaliforniaCity of Hope**RECRUITING NOW**Duarte, California, United States, 91010Contact: Samantha Humpal    626-218-9401    shumpal@coh.org   Principal Investigator: Anthony Stein, MD         United States, TexasMD Anderson Cancer Center**RECRUITING NOW**Houston, Texas, United States, 77030Contact: Danielle Nguyen    713-792-4133    dtnguyen7@mdanderson.org   Principal Investigator: Nicholas Short, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 29, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments